AKBAL, C. Et Al. 2017. S24-2: The Value of Urinary BDNF Levels on Assessment of The Botulinum Toxin Type A Treatment For Neurogenic Detrussor Overactivity in Children With Myelodysplasia. 28th Congress of ESPU , (BARSELONA, Spain), 256.

AKBAL, C., ŞEKERCİ, Ç. A., TANIDIR, Y., TOP, T., İŞBİLEN BAŞOK, B., İŞMAN, F. K., ... ŞİMŞEK, F.(2017). S24-2: The Value of Urinary BDNF Levels on Assessment of The Botulinum Toxin Type A Treatment For Neurogenic Detrussor Overactivity in Children With Myelodysplasia . 28th Congress of ESPU (pp.256). BARSELONA, Spain

AKBAL, CEM Et Al. "S24-2: The Value of Urinary BDNF Levels on Assessment of The Botulinum Toxin Type A Treatment For Neurogenic Detrussor Overactivity in Children With Myelodysplasia," 28th Congress of ESPU, BARSELONA, Spain, 2017

AKBAL, CEM Et Al. "S24-2: The Value of Urinary BDNF Levels on Assessment of The Botulinum Toxin Type A Treatment For Neurogenic Detrussor Overactivity in Children With Myelodysplasia." 28th Congress of ESPU , BARSELONA, Spain, pp.256, 2017

AKBAL, C. Et Al. (2017) . "S24-2: The Value of Urinary BDNF Levels on Assessment of The Botulinum Toxin Type A Treatment For Neurogenic Detrussor Overactivity in Children With Myelodysplasia." 28th Congress of ESPU , BARSELONA, Spain, p.256.

@conferencepaper{conferencepaper, author={CEM AKBAL Et Al. }, title={S24-2: The Value of Urinary BDNF Levels on Assessment of The Botulinum Toxin Type A Treatment For Neurogenic Detrussor Overactivity in Children With Myelodysplasia}, congress name={28th Congress of ESPU}, city={BARSELONA}, country={Spain}, year={2017}, pages={256} }